Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
- PMID: 19395420
- PMCID: PMC2673344
- DOI: 10.1136/bmj.b1354
Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
Abstract
Objective: To determine the incidence of cervical cancer after several negative cervical smear tests at different ages.
Design: Prospective observational study of incidence of cervical cancer after the third consecutive negative result based on individual level data in a national registry of histopathology and cytopathology (PALGA).
Setting: Netherlands, national data. Population 218,847 women aged 45-54 and 445,382 aged 30-44 at the time of the third negative smear test.
Main outcome measures: 10 year cumulative incidence of interval cervical cancer.
Results: 105 women developed cervical cancer within 2 595,964 woman years at risk after the third negative result at age 30-44 and 42 within 1,278,532 woman years at risk after age 45-54. During follow-up, both age groups had similar levels of screening. After 10 years of follow-up, the cumulative incidence rate of cervical cancer was similar: 41/100,000 (95% confidence interval 33 to 51) in the younger group and 36/100,000 (24 to 52) in the older group (P=0.48). The cumulative incidence rate of cervical intraepithelial neoplasia grade I+ was twice as high in the younger than in the older group (P<0.001).
Conclusions: The risk for cervical cancer after several negative smear results by age 50 is similar to the risk at younger ages. Even after several negative smear results, age is not a good discriminative factor for early cessation of cervical cancer screening.
Conflict of interest statement
Competing interests: The department of public health of the Erasmus MC received a grant from GSK, a manufacturer of an HPV vaccine, for research on the cost effectiveness of HPV vaccination in 2007 and 2008. This research and manuscript were neither funded nor supported by GSK. RB has been participating since 1989 in the screening research group at the department. He has been affiliated with RAND since 2000. Since 2007, he has been a director of evidence based strategies-disease modelling and economic evaluation at Pfizer, who develop and sell various drugs for cancer and other diseases. This research and manuscript were neither funded nor supported by Pfizer.
Figures
Comment in
-
At what age should cervical screening stop?BMJ. 2009 Apr 24;338:b809. doi: 10.1136/bmj.b809. BMJ. 2009. PMID: 19395422 No abstract available.
References
-
- Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, et al. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer 2004;108:258-61. - PubMed
-
- Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gynaecol 1997;104:586-9. - PubMed
-
- Flannelly G, Monaghan J, Cruickshank M, Duncan I, Johnson J, Jordan J, et al. Cervical screening in women over the age of 50: results of a population-based multicentre study. Br J Obstet Gynaecol 2004;111:362-8. - PubMed
-
- Gustafsson L, Sparen P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995;63:804-9. - PubMed
-
- Ogilvie D. Early discharge of low-risk women from cervical screening. J Public Health Med 2001;23:272-7. - PubMed